CEO & President of Abattis Bioceuticals Corp., Robert Abenante, speaks on the medical marijuana company's many facets including: a vape line, extraction and laboratory services.
Abattis Bioceuticals Corp. (CSE:ATT) is a specialty life sciences and biotechnology company. Through its operations and wholly owned subsidiaries, the Company has a broad range of capabilities including cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to green markets in North America.
